MedTrace Logo

Sinus Balloon Dilation in Pediatric Patients

NCT02278484 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-04-11

Study results available
· View outcomes & findings →

Summary

Safety and effectiveness of sinus balloon dilation in patients 2-21 years old.

Conditions

  • Sinusitis

Interventions

DEVICE

XprESS device and PathAssist confirmation tools

Sponsors & Collaborators

  • Entellus Medical, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-09-30
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278484 on ClinicalTrials.gov